SANOFI
Sanofi India Limited (SANOFI) Stock Analysis
Sanofi India Limited is the Indian subsidiary of global healthcare company Sanofi, marketing pharmaceuticals and vaccines. It sells prescription medicines in diabetes, cardiology, and specialty therapies through medical representatives and hospitals. The company benefits from global R&D pipelines adapted for India. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - General
₹3,077.20
-0.06% 1W | -38.50% 52W
Market Cap
7.1k CR
P/E Ratio
21.9
52W High
₹5059
52W Low
₹3054
Div. Yield
7.77%
Beta
0.2
50 DMA
₹3262
200 DMA
₹3541.8
Profit Margin
17.9%
Inst. Own.
24.5%
⚠️ BREAKDOWN
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Sales | 515 | 491 | 469 | 511 | 464 | 524 | 515 |
| Expenses | 393 | 377 | 370 | 374 | 348 | 404 | 397 |
| Operating Profit | 122 | 114 | 100 | 137 | 116 | 120 | 118 |
| OPM % | 24% | 23% | 21% | 27% | 25% | 23% | 23% |
| Other Income | 57 | 82 | 77 | 41 | 21 | 2 | 14 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 10 |
| Profit before tax | 169 | 186 | 167 | 169 | 127 | 113 | 122 |
| Tax % | 27% | 18% | 18% | 19% | 19% | 27% | 25% |
| Net Profit | 123 | 152 | 138 | 137 | 103 | 82 | 91 |
| EPS in Rs | 53.43 | 66.04 | 59.87 | 59.39 | 44.87 | 35.74 | 39.70 |
| Metric | Dec 2023 | Dec 2024 |
|---|---|---|
| Sales | 1,996 | 2,013 |
| Expenses | 1,508 | 1,522 |
| Operating Profit | 488 | 491 |
| OPM % | 24% | 24% |
| Other Income | 317 | 78 |
| Interest | 2 | 2 |
| Depreciation | 36 | 37 |
| Profit before tax | 767 | 531 |
| Tax % | 21% | 22% |
| Net Profit | 603 | 413 |
| EPS in Rs | 262.13 | 179.70 |
| Dividend Payout % | 64% | 65% |
Shareholding Pattern
Promoters60.40%
FIIs5.61%
DIIs23.06%
Public10.94%
Promoters60.40%
FIIs5.57%
DIIs22.28%
Public11.75%
Promoters60.40%
FIIs5.55%
DIIs21.30%
Public12.75%
Promoters60.40%
FIIs5.65%
DIIs21.12%
Public12.84%
Promoters60.40%
FIIs5.69%
DIIs19.87%
Public14.05%
Promoters60.40%
FIIs6.71%
DIIs19.46%
Public13.43%
Promoters60.40%
FIIs6.11%
DIIs22.88%
Public10.61%
Promoters60.40%
FIIs5.58%
DIIs23.02%
Public11.01%
Promoters60.40%
FIIs5.65%
DIIs21.12%
Public12.84%
Promoters60.40%
FIIs5.69%
DIIs19.87%
Public14.05%
SANOFI
Holdings Analysis
Key strengths & risk signals
52
Overall
57
Fundamental
48
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 38.5% in the last year.
WEAK POSITION! Current price (3077.2) is below both moving averages.
WEAK! Trading at 1.2% of 52W range - near yearly lows.
Strengths (4)
EXCELLENT DIVIDEND! 7.77% yield - very high income potential.
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 33.6 - watch for reversal.
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 20,182 vs down days: 17,985. Ratio: 1.12x
Fundamental & Technical Analysis
52Overall
57Fundamental
48Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -12.6% (DECLINING, 2/15). Profit CAGR: -19.3% (DECLINING, 2/15).
Profit Margin
6/10
GOOD EFFICIENCY! 17.9% profit margin - above average profitability.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
10/10
EXCELLENT DIVIDEND! 7.77% yield - very high income potential.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 13.22% public ownership - strong promoter/institutional control.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (3262.0) is below 200-day average (3541.8) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (3077.2) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
0/10
POOR YEAR! Stock declined 38.5% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 20,182 vs down days: 17,985. Ratio: 1.12x
RSI
4/5
APPROACHING OVERSOLD! RSI at 33.6 - watch for reversal.
52W Range
1/5
WEAK! Trading at 1.2% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.1% (1 week), 3.8% (1 month), 9.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
SANOFI
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q3FY262026-03-05 | Concall PDF | |
| Q2FY262025-11-04 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - General · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SANOFI | ₹3,077.20 | 21.9 | 17.9% | -12.6% | -19.3% | -38.5% | 52 | BREAKDOWN | +20.1% | -18.6% | +7.7% | -7.3% |
| SENORES | ₹1,395.90 | 49.3 | 18.7% | 159.1% | 139.2% | +98.6% | 77 | BREAKDOWN | +55.8% | -2.8% | +35.9% | +2.9% |
| SANOFICONR | ₹4,001.60 | 34.7 | 28.0% | 27.0% | 20.7% | -21.0% | 72 | APPROACHING SUPPORT | +13.3% | +1.5% | +6.7% | +2.8% |
| MARKSANS | ₹337.50 | 29.6 | 16.3% | 16.7% | 16.2% | +83.7% | 79 | CONSOLIDATING DOWN | +169.6% | +6.1% | +35.6% | -1.8% |
| PFIZER | ₹4,035.00 | 25.1 | 28.6% | 1.3% | 5.0% | -21.0% | 48 | BREAKDOWN | +6.6% | +2.4% | +8.3% | +3.8% |
| SMSPHARMA | ₹467.40 | 42.2 | 11.4% | 19.3% | – | +56.3% | 77 | BREAKOUT | +2.0% | -36.1% | +5.6% | -13.0% |
| SAIPARENT | ₹508.60 | 114.5 | 3.9% | 126.1% | 111.8% | +25.9% | 69 | BREAKDOWN | +464.3% | -1,416.7% | +435.0% | -33.6% |
| NGLFINE | ₹2,724.00 | 29.4 | 10.7% | 21.8% | 32.9% | +94.5% | 80 | BOUNCE FROM SUPPORT | +100.0% | +36.3% | +33.6% | -6.7% |
Data from TradeAlone · Updated daily
